Phase
Condition
Thyroid Cancer
Neuroblastoma
Carcinoma
Treatment
standard-of-care imaging (18F-FDG and 68Ga-FAPI PET/CT), 68Ga-THP-Trop2 VHH PET/CT
Clinical Study ID
Ages 18-90 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult patients (aged 18 years or older);
Patients with newly diagnosed, highly suspected recurrence or previously treatedmetastases of thyroid cancer (supporting evidence may include MRI, CT, tumormarkers, and pathology report);
Patients who had scheduled both standard-of-care imaging (18F-FDG and 68Ga-FAPIPET/CT) and 68Ga-THP-Trop2 VHH PET/CT scans;
Patients who were able to provide informed consent (signed by participant, parent orlegal representative) and assent according to the guidelines of the ClinicalResearch Ethics Committee.
Exclusion
Exclusion Criteria:
Patients with pregnancy;
The inability or unwillingness of the research participant, parent or legalrepresentative to provide written informed consent.
Study Design
Study Description
Connect with a study center
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian 361003
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.